Skip to main content
. 2019 Jul 16;11:6603–6614. doi: 10.2147/CMAR.S204346

Table 13.

Number (percentage) of patients in groups differing in chemotherapy and a 12-month survival or a 24-month survival, the result of the test of independence, OR, adjusted by N odds ratio (ORadj.) and their 95% CI

Chemotherapy 12-month survival P-value OR (95% CI) ORadj. (95% CI)
Yes
N=129
No
N=104
Yes 85 (65.9%) 50 (48.1%) 0.006 2.09 (1.23–3.54) 8.05 (4.38–14.8)
No 44 (34.1%) 54 (51.9%) 1.00 (ref.) 1.00 (ref.)
Chemotherapy 24-month survival P-value OR (95% CI) ORadj. (95% CI)
Yes
N=83
No
N=150
Yes 55 (66.3%) 80 (53.3%) 0.056 1.72 (0.99–3.00) 4.86 (2.55–9.25)
No 28 (33.7%) 70 (46.7%) 1.00 (ref.) 1.00 (ref.)